Delivery Order SPE2DB24D2101-SPE2DB25FKHJW
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$76K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to AmerisourceBergen Drug Corp, Corporate Office Division, for the delivery of SKYRIZI 150 MG/ML SYRINGEML, a pharmaceutical product. The contract, valued at $11,827.51, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of SKYRIZI 150 MG/ML PENML medical products. The contract has a ceiling value of $17,695.19 and is a Firm Fixed Price Delivery Order, with a period of performance through November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,656.75 and is a Firm Fixed Price Delivery Order with Amerisourcebergen Drug Corp as the prime contractor. The contract has an ultimate completion date of February 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,456.34, is a delivery order for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of SKYRIZI 150 MG/ML PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,482.49 and an ultimate completion date of April 24, 2024. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of SKYRIZI 150 MG/ML PENML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $18,555.19 and an ultimate completion date of January 13, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $72,356.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a completion date of June 4, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,795.46 firm-fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML SYRINGE, a specialty medication. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,209.26 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, a medical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not set aside for any specific business type. This award is part of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $23,953.03, is for the delivery of SKYRIZI 150 MG/ML Prefilled Syringes. This is a Firm Fixed Price Delivery Order contract with a performance period ending on January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...